Martin Hunt

Accomplished executive and NED, with extensive international experience and a track record of success in leadership and strategic roles within the life sciences sector, spanning large multi-nationals, AiM listed plc, early stage ventures and public sector roles.


I have held senior roles in several MedTech companies during more than 30 years working in the life sciences industry. I was CEO of Tissue Science Laboratories (TSL), and took the company from a start-up into an international business floated on the London Stock Exchange. Since TSL was sold in 2008 to Covidien, I have acted as a Chairman, non-executive director, investor and mentor to a wide range of dynamic companies in the UK and Europe.

I'm currently Chairman of SkinBioTherapeutics and Videregen, and I am also the Medtech Industry Engagement Advisor to the National Institute for Health Research. I am involved with a number of other institutions working in the life sciences space, for example as a Board member on the Imperial College Department of Bioengineering’s Industrial Advisory Board and a member of the Imperial Technology Experts Service (ITES).

Work with me

Happy to look at new projects with great people and innovative technologies.